Dr. Natalya Chernichenko, MD

Dr. Chernichenko practices at Kings Physician Services in Yorktown Heights, New York.

Dr. Chernichenko's NPI, 1255500906, was assigned on February 27, 2008. Dr. Chernichenko graduated from SUNY Downstate Health Sciences University in 2005. Dr. Chernichenko holds New York license 256339-1.

Dr. Chernichenko's primary practice is Kings Physician Services, at 2649 Strang Blvd, Yorktown Heights, NY 10598 in Westchester County. The practice phone is (718) 780-5051.

Dr. Chernichenko's primary practice is Kings Physician Services in Yorktown Heights, New York. Dr. Chernichenko is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group/Westchester. Dmand AI also links Dr. Chernichenko to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chernichenko practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Chernichenko's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Chernichenko is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Chernichenko is licensed in New York.

Dmand AI lists chronic nasal allergies, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease, swimmer's ear, thyroid surgery and tinnitus among the conditions Dr. Chernichenko treats.

CMS data shows 908 Medicare services from Dr. Chernichenko across 10 procedure codes in 2024, for 311 Medicare patients. Medicare paid $57,790 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 311 Medicare patients who saw Dr. Chernichenko in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chernichenko's median patient age at 67, with 71% women.

In 2024, Dr. Chernichenko wrote 1,640 Medicare Part D claims for 418 patients. 99% of them were for generic drugs. CMS names the drug for 1,538 of them, across 16 drugs with 11 or more claims each, at $21,855 in total drug cost. In 2023, CMS named 1,134 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Chernichenko for performance year 2024, reported as part of a group. Dr. Chernichenko accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chernichenko as offering telehealth.

Dmand AI links 28 papers to Dr. Chernichenko, published from 2011 to 2023. 2011 was the busiest year, with 5. The most frequent topics are Mice, Nude, Cell Line, Tumor and Neoplasm Invasiveness. Dr. Chernichenko has published most often in J Mol Biol. Dr. Chernichenko's most frequent co-authors are Richard J. Wong, MD, Richard L. Bakst, MD and William Francis McNamara, MD.

CMS Open Payments shows 22 general payments to Dr. Chernichenko from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Cambridge Interventional LLC paid the most, $329.

Dr. Chernichenko graduated from SUNY Downstate Health Sciences University in 2005.

Dr. Chernichenko is in network with 7 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.